Analysts Downgrades

GCP Applied Technologies Inc. (GCP) Rating Lowered to Hold at Zacks Investment Research

GCP Applied Technologies Inc. (GCP) Rating Lowered to Hold at Zacks Investment Research

GCP Applied Technologies Inc. (NYSE:GCP) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday. According to Zacks, “GCP Applied Technologies Inc. offer specialty construction chemicals and building materials as well as packaging technologies. GCP Applied Technologies Inc. is headquatered Cambridge, Massachusetts. “ Separately, Jefferies […]
Endeavour Silver Corporation (EXK) Rating Lowered to Sell at Zacks Investment Research

Endeavour Silver Corporation (EXK) Rating Lowered to Sell at Zacks Investment Research

Endeavour Silver Corporation (NYSE:EXK) (TSE:EDR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. According to Zacks, “ENDEAVOUR SILVER CORP. is a small-cap silver mining company focused on the growth of its silver production, reserves and resources in Mexico. The expansion programs […]
e.l.f. Beauty Inc. (ELF) Lowered to “Hold” at Zacks Investment Research

e.l.f. Beauty Inc. (ELF) Lowered to “Hold” at Zacks Investment Research

e.l.f. Beauty Inc. (NYSE:ELF) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday. According to Zacks, “e.l.f. Beauty, Inc. operates as a cosmetic company. Its cosmetic category primarily consists of face makeup, eye makeup, lip products, nail products and cosmetics sets/kits, excludes beauty tools […]
Engility Holdings, Inc. (EGL) Lowered to “Hold” at Zacks Investment Research

Engility Holdings, Inc. (EGL) Lowered to “Hold” at Zacks Investment Research

Engility Holdings, Inc. (NYSE:EGL) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a report issued on Tuesday. According to Zacks, “Engility Holdings, Inc. is engaged in providing government services in engineering, professional support and mission support to customers in the U.S. Department of Defense, Federal civilian agencies and […]
Dynagas LNG Partners LP (DLNG) Downgraded by Zacks Investment Research

Dynagas LNG Partners LP (DLNG) Downgraded by Zacks Investment Research

Dynagas LNG Partners LP (NYSE:DLNG) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Tuesday. According to Zacks, “Dynagas LNG Partners LP is focused on owning and operating LNG carriers that are employed on multi-year contracts with international energy companies. Dynagas LNG […]
Compass Diversified Holdings (CODI) Downgraded to Sell at Zacks Investment Research

Compass Diversified Holdings (CODI) Downgraded to Sell at Zacks Investment Research

Compass Diversified Holdings (NYSE:CODI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. According to Zacks, “COMPASS DIVERSIFIED was formed to acquire and manage a group of middle market businesses that are headquartered in North America. CODI provides public […]
Zacks Investment Research Lowers Cone Midstream Partners LP (CNNX) to Hold

Zacks Investment Research Lowers Cone Midstream Partners LP (CNNX) to Hold

Cone Midstream Partners LP (NYSE:CNNX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday. According to Zacks, “CONE Midstream Partners LP owns, operates, develops and acquires natural gas gathering and other midstream energy assets. The Company’s initial assets include natural gas gathering pipelines and […]
Chiasma, Inc. (CHMA) Lowered to Hold at Zacks Investment Research

Chiasma, Inc. (CHMA) Lowered to Hold at Zacks Investment Research

Chiasma, Inc. (NASDAQ:CHMA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday. According to Zacks, “Chiasma, Inc. is a biopharmaceutical company. The company’s TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical […]
Central European Media Enterprises Ltd. (CETV) Rating Lowered to Hold at Zacks Investment Research

Central European Media Enterprises Ltd. (CETV) Rating Lowered to Hold at Zacks Investment Research

Central European Media Enterprises Ltd. (NASDAQ:CETV) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday. According to Zacks, “Central European Media Enterprises Ltd. Is involved in the Media and Advertising Industry. They invest in, develop and operate national and regional commercial television stations […]
Quality Systems, Inc. (QSII) Lowered to Sell at Zacks Investment Research

Quality Systems, Inc. (QSII) Lowered to Sell at Zacks Investment Research

Quality Systems, Inc. (NASDAQ:QSII) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday. According to Zacks, “Over the past six months, Quality Systems has outperformed the broader industry trends with respect to price performance. However, the estimation trends for the stock are mixed at […]
Regency Centers Corporation (REG) Downgraded by Zacks Investment Research

Regency Centers Corporation (REG) Downgraded by Zacks Investment Research

Regency Centers Corporation (NYSE:REG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday. According to Zacks, “Regency is slated to report its fourth-quarter and full year 2016 earnings results on Feb 8, after the market closes. The company recently updated its core 2016 funds […]
Rayonier Inc. (RYN) Stock Rating Lowered by Zacks Investment Research

Rayonier Inc. (RYN) Stock Rating Lowered by Zacks Investment Research

Rayonier Inc. (NYSE:RYN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. According to Zacks, “Shares of Rayonier outperformed the Zacks categorized Building Product – Wood industry over the past one month. However, its 2017 earnings per share (EPS) […]
Teradyne, Inc. (TER) Downgraded by Zacks Investment Research to Sell

Teradyne, Inc. (TER) Downgraded by Zacks Investment Research to Sell

Teradyne, Inc. (NYSE:TER) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday. According to Zacks, “Teradyne is a leading provider of automated test equipment. Over the last one year, the stock has outperformed the Zacks Electronics – Testing Equipment industry. A recovery in the […]
Texas Instruments Incorporated (TXN) Rating Lowered to Hold at Zacks Investment Research

Texas Instruments Incorporated (TXN) Rating Lowered to Hold at Zacks Investment Research

Texas Instruments Incorporated (NASDAQ:TXN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday. According to Zacks, “Texas Instruments is one of the largest suppliers of analog integrated circuits. The company’s third-quarter results exceeded the Zacks Consensus Estimate.  Margins expanded and should continue to expand […]
Blueknight Energy Partners L.P., L.L.C. (BKEP) Stock Rating Lowered by Zacks Investment Research

Blueknight Energy Partners L.P., L.L.C. (BKEP) Stock Rating Lowered by Zacks Investment Research

Blueknight Energy Partners L.P., L.L.C. (NASDAQ:BKEP) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. According to Zacks, “Blueknight Energy Partners, L.P., based in Tulsa, Oklahoma, owns and operates a diversified portfolio of complementary midstream energy assets. It provides […]
Zacks Investment Research Downgrades BeiGene, Ltd. (BGNE) to Hold

Zacks Investment Research Downgrades BeiGene, Ltd. (BGNE) to Hold

BeiGene, Ltd. (NASDAQ:BGNE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. According to Zacks, “BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company’s clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. […]
Zacks Investment Research Lowers Avinger, Inc. (AVGR) to Hold

Zacks Investment Research Lowers Avinger, Inc. (AVGR) to Hold

Avinger, Inc. (NASDAQ:AVGR) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Tuesday. According to Zacks, “Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company’s product consists of Lightbox imaging console, Wildcat, Kittycat, […]
Air Transport Services Group, Inc (ATSG) Stock Rating Lowered by Zacks Investment Research

Air Transport Services Group, Inc (ATSG) Stock Rating Lowered by Zacks Investment Research

Air Transport Services Group, Inc (NASDAQ:ATSG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday. According to Zacks, “AIR TRANSPORT SERVICES GROUP, INC. is a leading provider of air cargo transportation and related services to domestic and foreign air carriers and other companies […]
Aldeyra Therapeutics, Inc. (ALDX) Stock Rating Lowered by Zacks Investment Research

Aldeyra Therapeutics, Inc. (ALDX) Stock Rating Lowered by Zacks Investment Research

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday. According to Zacks, “Aldeyra Therapeutics, Inc. is a biotechnology company. The company’s products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free […]
Zacks Investment Research Lowers Aimmune Therapeutics, Inc. (AIMT) to Hold

Zacks Investment Research Lowers Aimmune Therapeutics, Inc. (AIMT) to Hold

Aimmune Therapeutics, Inc. (NASDAQ:AIMT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday. According to Zacks, “Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company’s characterized oral desensitization immunotherapy […]
Diebold, Incorporated (DBD) Cut to Sell at Zacks Investment Research

Diebold, Incorporated (DBD) Cut to Sell at Zacks Investment Research

Diebold, Incorporated (NYSE:DBD) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Tuesday. According to Zacks, “Diebold Incorporated develops, manufactures, sells and services automated teller machines, electronic and physical security systems, various products used to equip bank facilities, software and integrated systems for global […]
DAQO New Energy Corp. (DQ) Downgraded to Hold at Zacks Investment Research

DAQO New Energy Corp. (DQ) Downgraded to Hold at Zacks Investment Research

DAQO New Energy Corp. (NYSE:DQ) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a report issued on Tuesday. According to Zacks, “Daqo New Energy Corp. is engaged in the manufacture and sale of high-quality polysilicon to photovoltaic product manufacturers. The polysilicon is further processed into ingots, wafers, cells […]
Zacks Investment Research Lowers Curis, Inc. (CRIS) to Hold

Zacks Investment Research Lowers Curis, Inc. (CRIS) to Hold

Curis, Inc. (NASDAQ:CRIS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday. According to Zacks, “Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. […]
Dicerna Pharmaceuticals, Inc. (DRNA) Downgraded to Hold at Zacks Investment Research

Dicerna Pharmaceuticals, Inc. (DRNA) Downgraded to Hold at Zacks Investment Research

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued on Tuesday. According to Zacks, “Dicerna Pharmaceuticals, Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The company uses its […]
California Resources Corporation (CRC) Downgraded to “Sell” at Zacks Investment Research

California Resources Corporation (CRC) Downgraded to “Sell” at Zacks Investment Research

California Resources Corporation (NYSE:CRC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. According to Zacks, “California Resources Corporation is engaged in exploration and production of oil and gas. The Company produces, gathers, processes and markets crude oil, natural […]
Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.